Is Zinbryta (daclizumab) still available?

No, Zinbryta (daclizumab) has been discontinued and is no longer available in the United States.

Why was Zinbryta (daclizumab) discontinued?

Zinbryta (daclizumab) was discontinued due to concerns of [having more safety risks with taking the medication than its benefits](https://www.fda.gov/drugs/drug-safety-and-availability/fda-working-manufacturers-withdraw-zinbryta-market-united-states). Some of these safety risks included liver injury and other immune-related problems.

What other medications can I use in place of Zinbryta (daclizumab)?

While Zinbryta (daclizumab) has been discontinued, there are still several [other medications available for the treatment of MS](https://www.nationalmssociety.org/Treating-MS/Medications). Examples include [glatiramer (Copaxone)](https://www.goodrx.com/glatiramer/what-is), [Kesimpta (ofatumumab)](https://www.goodrx.com/kesimpta/what-is), and [Gilenya (fingolimod)](https://www.goodrx.com/gilenya/what-is). Your provider will help guide you to the best treatment option for your MS.

Zinbryta

Q: What is Zinbryta (daclizumab)?

Zinbryta (daclizumab) is a [monoclonal antibody](https://www.goodrx.com/classes/monoclonal-antibodies) used to treat relapsing forms of MS. It's not exactly known how it works, but it's thought to work by [turning off certain proteins and processes](https://link.springer.com/article/10.1007/s13311-017-0553-8) in your brain to lower [inflammation](https://www.goodrx.com/health-topic/autoimmune/what-is-inflammation) and treat symptoms of MS.

daclizumab

Used for Multiple Sclerosis

Zinbryta (daclizumab) is a medication used to treat relapsing forms of multiple sclerosis (MS) in adults. It's no longer available in the United States, because it was discontinued.

Reviewed by:

Robert Chad Hakim, PharmD, BCCCP

Kristianne Hannemann, PharmD

Last reviewed on July 12, 2022

What is Zinbryta (daclizumab)?

What is Zinbryta (daclizumab) used for?

Relapsing forms of multiple sclerosis (MS)

Drug facts

Common Brands	Zinbryta(brand no longer available)
Drug Class	Monoclonal antibody
Controlled Substance Classification	Not a controlled medication
Generic Status	No lower-cost generic available
Availability	Discontinued

Common Brands

Zinbryta(brand no longer available)

Drug Class

Monoclonal antibody

Controlled Substance Classification

Not a controlled medication

Generic Status

No lower-cost generic available

Availability

Discontinued

Common questions about Zinbryta

Zinbryta is a monoclonal antibody used to treat relapsing forms of MS. It's not exactly known how it works, but it's thought to work by turning off certain proteins and processes in your brain to lower inflammation and treat symptoms of MS.

No, Zinbryta has been discontinued and is no longer available in the United States.

Zinbryta was discontinued due to concerns of having more safety risks with taking the medication than its benefits. Some of these safety risks included liver injury and other immune-related problems.

While Zinbryta has been discontinued, there are still several other medications available for the treatment of MS. Examples include glatiramer (Copaxone), Kesimpta (ofatumumab), and Gilenya (fingolimod). Your provider will help guide you to the best treatment option for your MS.